Researchers can now investigate long-term effects of OCs on cancer.
Rubin
G L
GL
Peterson
H B
HB
D000569:Americas; D001695:Biology; D001943:Breast Neoplasms; D003267:Contraception; D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003276:Contraceptives, Oral; D003872:Dermatitis; D019049:Developed Countries; D003906:Developing Countries; D004194:Disease; D016889:Endometrial Neoplasms; D005193:Family Planning Services; D008113:Liver Neoplasms; D008548:Melanosis; D009369:Neoplasms; D009656:North America; D010051:Ovarian Neoplasms; D010827:Physiology; D012867:Skin; D014481:United States; D002583:Uterine Cervical Neoplasms
D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003276:Contraceptives, Oral
Americas; Biology; Breast Cancer; Cancer; Cervical Cancer; Contraception--beneficial effects; Contraception--side effects; Contraceptive Agents, Female--beneficial effects; Contraceptive Agents, Female--side effects; Contraceptive Agents--beneficial effects; Contraceptive Agents--side effects; Contraceptive Methods--beneficial effects; Contraceptive Methods--side effects; Dermatitis; Dermatological Effects; Developed Countries; Developing Countries; Diseases; Endometrial Cancer; Family Planning; Liver Neoplasms; Melanosis; Neoplasms; North America; Northern America; Oral Contraceptives--beneficial effects; Oral Contraceptives--side effects; Ovarian Cancer; Physiology; United States